Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The ACR on Air Podcast’s COVID-19 Series

From the College  |  Issue: June 2020  |  June 15, 2020

3D generator; JPC-PROD / shutterstock.com

3D generator; JPC-PROD / shutterstock.com

In light of the current COVID-19 pandemic, the ACR has dedicated a few episodes of the ACR on Air podcast to the challenges that have arisen, along with information about the available resources and guidance.

The first episode in this special series looks at drug shortages surrounding hydroxy­chloroquine (HCQ) and its initial uses to treat the coronavirus. In this episode, the host talks with ACR President-Elect David Karp, MD, PhD, and Amanda Grimm Wiegrefe, ACR director of regulatory affairs.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The series continues with a discussion on how to keep your practice going during the pandemic. Our host chats with Chris Phillips, MD, who runs a solo practice in Kentucky, and Dan Redinger, ACR manager of advocacy and political affairs, who is keeping his eye on the federal COVID-19 stimulus package. The guests share best practices and tips for healthcare providers during this unprecedented time.

In the midst of the COVID‑19 pandemic, rheumatologists and rheumatology professionals have found themselves in an unprecedented situation in which the rise of telehealth has been key to treating their patients. In the next episode of the series, the host speaks with two experts, Jay Mehta, MD, MS, the Children’s Hospital of Philadelphia, and Antanya Chung, ACR director of practice management, about telehealth best practices.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Experiencing COVID-19-related drug shortages, practice issues or any other problems? Send your comments and questions to [email protected].

Share: 

Filed under:From the CollegePractice Support Tagged with:ACR on Air podcastCOVID-19

Related Articles

    Telehealth Brings Opportunities to Enhance Patient Care

    December 8, 2022

    During an ACR webinar in August, presenters discussed multiple aspects of telehealth in rheumatology, especially related to rheumatology fellowship training. They agreed that although telehealth represents one potential avenue to improve patient access to treatment for rheumatic disease, we must keep identifying the best ways to employ telehealth to enhance care. Impact of Pandemic Telemedicine…

    Telerheumatology: What’s Next?

    December 17, 2020

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

    What’s Next for Telehealth after the COVID-19 Public Health Emergency?

    June 10, 2023

    Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…

    Rheumatology in a COVID & Post-COVID World

    May 11, 2020

    Jane’s* hands and wrists had been swollen and painful for about eight weeks. Lab findings in the ambulatory consult that came to our office revealed a cyclic citrullinated peptide antibody count >250 u/mL. We all know where this story goes, including how important the early treatment window is. Our clinic reviews all consults and tries…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences